滋阴降火清胃法对特发性中枢性性早熟女童血清激素水平的影响
|
摘要
研究背景:性早熟系一种生长发育异常疾病,表现为青春期提前启动,第二性征提前出现。其中以特发性中枢性性早熟(ICPP)患儿最为多见,占性早熟患儿的92%,目前研究表明,该病对患儿生理、心理、生活及学习均有不同程度的影响,并可影响其骨龄的发育及最终身高。近年来性早熟发病率逐年上升,性早熟已成为儿童内分泌科常见病之一,且患病女孩80%～90%为ICPP,因此女童ICPP的研究成为性早熟研究中的焦点。目前,ICPP的病因尚未完全明确,现认为主要是由于下丘脑-垂体-性腺轴(HPGA)功能提前激活所致。西医药对于ICPP女童的治疗,临床应用最多的为促性腺激素释放激素拟似物(GnRHa)。GnRHa价格昂贵,投放临床应用时间较短,其药物安全性尚待进一步考证,且近年有报道其可同时抑制生长激素(GH)分泌,影响身高。中医认为人体正常的生长发育及性腺的成熟,主要靠肾气的充盛及天癸的期至。若各种原因致肾阴阳失衡,天癸早至,则可引起儿童性成熟的提前而发病。目前认为性早熟的病因病机主要有:肾阴不足;肝郁化火;脾虚痰凝;湿浊下注等。但临床ICPP女童以肾阴不足、阴虚火旺者居多,且在临床实践中我们发现ICPP患儿除有阴虚火旺的症候表现外,多伴有多食易饥、面部痤疮等胃热炽盛、虚火上炎的表现。在运用中医药治疗本病的实践中,我们发现中药不仅可使患儿第二性征消退,亦可降低血清性激素水平,且对患儿治疗期间的生长发育无明显影响。故本研究根据小儿具有“阴常不足,阳常有余”,“肝常有余,肾常虚”的病理特点,提出以滋阴降火清胃为治则,自拟早熟一方治疗ICPP,选取促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E_2)和生长激素(GH)水平为主要的研究指标,及盆腔B超、骨龄、体重、身高、临床症状等多方面进行临床疗效的观察,以期进一步了解中药对HPGA、促生长激素轴的功能活动、血清激素水平及生长发育的影响。
研究目的:通过观察治疗前后患儿青春期性征、体重、身高、骨龄等的变化,进一步对早熟一方治疗ICPP临床疗效进行科学的论证;通过观察治疗前后患儿血清FSH、LH、E_2水平的变化,了解早熟一方对患儿激素水平的影响;通过观察治疗前后患儿血清中GH变化,了解早熟一方对患儿生长激素水平的影响;并试图探讨促生长激素轴及促性腺轴之间的相互关系,以及它们在ICPP发病机制中的作用,从而进一步探讨早熟一方的作用机制。
本研究从患儿血清中GH的变化以及与FSH、LH、E_2的变化间的相互关系,试图了解促生长激素轴和促性腺轴之间的相互关系,并从这些全新的角度探讨ICPP的发病机制及早熟一方治疗ICPP的作用机理,证实滋阴降火清胃法治疗本病的优势所在和特点及其药物安全性,为中医药治疗本病提供新的治疗思路和途径。
研究方法:研究对象共50例女童,均为2006年1月—2008年3月在广州市中医医院儿科门诊就诊并确诊为ICPP的女童,按就诊先后顺序随机分为治疗组和对照组各25例,治疗组予早熟一方口服,每日2次;对照组予知柏地黄丸,每次6丸,每日2次。两组用药时间均为6个月,治疗期间均无合并其他疗法。治疗前后对临床症状、体征、FSH、LH、E_2、GH、盆腔B超、骨龄、体重、身高、肝肾功能等进行比较。全部数据以均数±标准差((?)±s)表示,组间比较:方差齐的采用两组独立样本的t检验,方差不齐的采用秩和检验;治疗前后比较采用配对样本的t检验;计数资料采用x~2检验。分析均由SPSS11.3软件包完成。
结果:
1.两组疗效比较:
两组总有效率分别为:治疗组88%,对照组56%,两组比较有显著性差异(P＜0.05)。
2.两组临床症状缓解的起效时间:
两组头晕、五心烦热、多食善饥、面部痤疮的缓解起效时间比较有显著性差异(P＜0.05),而潮热、盗汗的缓解起效时间比较无显著性差异(P＞0.05)。
3.两组治疗前后乳房直径:
两组治疗前后乳房大小比较均有显著性差异(P＜0.05)。但两组治疗前乳房大小比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
4.子宫、卵巢体积:
治疗组治疗前后子宫体积比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。且两组治疗前子宫体积比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
5.血清FSH水平:
治疗组治疗前后血清FSH比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。且两组治疗前血清FSH比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
6.血清LH水平:
治疗组治疗前后血清LH比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。而两组治疗前后血清LH比较无显著性差异(P＞0.05)。
7.血清E_2水平:
两组治疗前后血清E_2比较均有显著性差异(P＜0.05)。但两组治疗前血清E_2比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
8.GH水平:
两组治疗前后血清生长激素比较均无显著性差异(P＞0.05)。两组治疗前后血清生长激素比较亦无显著性差异(P＞0.05)。
9.BA/CA(骨龄/实际年龄):
治疗组治疗前后BA/CA比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。两组治疗前血清BA/CA比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
10.两组治疗前后身高、体重比较无显著性差异(P＞0.05)。
11.药物的不良反应:治疗组不良反应总发生率8%,对照组不良反应总发生率16%,两组比较无显著性差异(P＞0.05)。
结论:
1.早熟一方对头晕、五心烦热、多食善饥、面部痤疮等肾阴亏虚、胃火旺盛等症状的疗效优于知柏地黄丸。
2.早熟一方可缩小患儿肿大的乳房及增大的子宫和卵巢体积,且效果优于知柏地黄丸。
3.早熟一方不仅可降低ICPP患儿体内E_2水平,还可降低其血清FSH、LH水平,说明其可能具有抑制ICPP患儿HPGA轴的功能。
4.早熟一方在降低ICPP患儿体内性激素水平的同时GH水平没有降低。且患儿骨龄增长速度低于知柏地黄丸组。间接证明其对于生长激素轴没有明显的抑制,且患儿骨龄超前得以一定程度缓解,生长潜力增高。
5.早熟一方治疗组不良反应发生率低,应用本方治疗女童ICPP是安全可行的。
Background:
Precocious puberty is a kind of growth and developmental abnormality that is characterized as premature start of adolescence and secondary sexual character,among which idiopathic central precocious puberty(ICPP)is the most common one(92%of children with precocious puberty).Researches show it has impact on children' s physiology,mental health,lives and study;it can also effect the development of bone age and body height.In recent years, prevalence of precocious puberty increases steadily and it has become a common endocrine disease in children.80%-90%of endocrine disease in girls is ICPP, so ICPP in girls has become the focus in the study of precocious puberty.Until now its etiology is unclear,which is believed to be the result of activation of HPGA in advance.In western medicine,gonadotropin releasing hormone analogues(GnRHa)are the usual agent in treating ICPP of girls.GnRHa are expensive and its safety needs further appraisal because of its short application period in clinics,further more,it is report to inhibit secretion of GH and has negative impact to body height in recent years.It is thought from the point of TCM that normal growth and development and maturation of genital gland mainly depend on sufficient kidney-qi and menstruation beginning on time.If there are imbalance between kidney-yin and kidney-yang and menstruation is ahead of time,it will cause disease by bringing sexual maturity of children forward.It is regarded that the main etiology and pathogenesis of precocious puberty is:inefficiency of kidney-yin;pathogenic fire derived from stagnation of liver-QI;stagnation of phlegm caused by splenic asthenia;flowing down of pathogenic damp and etc.But in clinic inefficiency of kidney-yin and asthenic yin causing excessive pyrexia are the main symptoms of girls with ICPP.In clinic,we find that children with ICPP are always accompanied with symptoms of excessive gastric heat and hyperactivity of deficient fire such as polyphagia,easy to be hungry and acne in the face besides asthenic yin causing excessive pyrexia.During treatment of the disorder with traditional Chinese medicine(TCM),we found that TCM can not only decrease secondary sexual character of children patients,but also decrease serum level of sex hormone(FSH,LH,E_2)and has no impact to growth and development of the children during treating period.In the study, based on pathologic character of "yin frequently in deficiency,yang frequently in excess" and "liver frequently in excess,asthenic susceptibility of kidney" in children,we propose nourishing yin to lessen fire and clear stomach as therapeutical principle and prescribed Zaoshu Yifang to treat ICPP.We choose hormone(FSH,LH,E_2,GH)level in serum as the main index and ultrasound examination Of pelvic cavity,bone age,body weight,body height and clinical symptoms as parameters of curative effect.From the study, we hope to further investigate influence of TCM to functional activity of HPGA and somatotropic hormone-axle,hormone level in serum,growth and development.
Objective:
Appraisal clinical curative effect of Zaoshu Yifang to ICPP in scientific manner by observation of changes of sexual characteristics during adolescence, body weight,body height and bone age before and after the treatment; investigate impact of Zaoshu Yifang to hormone level of children patients by observation of changes of FSH,LH and E2 before and after the treatment;by observation of changes of GH level,study impact of Zaoshu Yifang to growth hormone of children patients,investigate interrelationship between somatotropic hormone-axle and gonadotropic hormone-axle and their role in pathogenesis of ICPP and further study the mechanism of action of Zaoshu Yifang.
In the study,we try to study interrelationship between somatotropic hormone-axle and gonadotropic hormone-axle from changes of GH level and its relationship with changes of FSH,LH and E2,investigate pathogenesis of ICPP and mechanism of action of Zaoshu Yifang to ICPP from these fresh new point of view,verify advantages of nourishing yin to lessen fire and clear kidney in treating the disorder and drug safety and provide new therapeutic method in treating the disorder by TCM.
Methods:
50 girls diagnosed to be ICPP in outpatient pediatric clinic in Guangzhong Hospital of Chinese Medicine(from January,2006 to April,2008)were randomly divided into treatment group and control group with 25 girls in each group. Treatment group were treated with Zaoshu Yifang,twice per day;Control group were treated with Zhibaidihuang Pill,6 pills per time,twice per day.Treating time is 6 months in both groups and without additional treatment.Clinical symptoms and signs,FSH,LH,E_2,GH,ultrasound examination of pelvic cavity, bone age,body weight,body height,liver function and renal function were compared before and after treatment.Results were showed as X±s.Group comparison:independent t test was used for homogeneity of variance and rank sum test was used for heterogeneity of variance.Comparison before and after treatment:paired t test was used for measurement data andχ~2 test was used for enumeration data.SPSS11.3 software was used for analysis.
Results:
1.Comparison of therapeutic effect:
There is significant difference of total effective rate between two groups (88%in treatment group and 56%in control group,P＜0.05).
2.Symptomatic relief time:
There is significant difference of symptomatic relief time between two groups in the symptom such as dizziness,burning sensation of five centres, polyphagia,boutimia,prosopo-acne(P＜0.05).But,there is no significant difference of symptomatic relief time between two groups in the symptom such as hectic fever、night sweat(P＞0.05).
3.Breasts diameter:
There is significant difference in breasts diameter before and after treatment both in two groups(P＜0.05).But,there is no significant difference between two groups before treatment(P＞0.05),there is significant difference between two groupsafter treatment(P＜0.05).
4.Volume of womb and ovaries:
There is significant difference in volume of womb and ovaries before and after treatment in treatment group(P＜0.05).But,there is no significant difference in volume of womb and ovaries before and after treatment in control group(P＞0.05).There is no significant difference between two groups before treatment(P＞0.05).And,there is significant difference between two groups after treatment(P＜0.05)
5.FSH level:
There is significant difference in FSH level before and after treatment in treatment group(P＜0.05)But,there is no significant difference in FSH level before and after treatment in control group(P＞0.05)There is no significant difference between two groups before treatment(P＞0.05)But, there is significant difference between two groups after treatment(P＜0.05).
6.LH level:
There is significant difference in LH level before and after treatment in treatment group(P＜0.05).But,there is no significant difference in LH level before and after treatment in control group(P＞0.05).There is no significant difference between two groups before and after treatment(P＞0.05).
7.E_2 level:
There is significant difference in E_2 level before and after treatment both in two groups(P＜0.05).There is no significant difference between two groups before treatment(P＞0.05)But,there is significant difference between two groups after treatment(P＜0.05).
8.GH level:
There is significant difference in E_2 level before and after treatment both in two groups(P＞0.05).And there is no significant difference between two groups before and after treatment(P＞0.05).
9.BA/CA(bone age/actual age):
There is significant difference in BA/CA before and after treatment in treatment group(P＜0.05).But,there is no significant difference in BA/CA before and after treatment in control group(P＞0.05).There is no significant difference between two groups before treatment(P＞0.05),But,there is significant difference between two groups after treatment(P＜0.05).
10.There is no significant difference of body height and body weight between two groups before and after treatment(P＞0.05).
11.idverse effect of the drug:
Total incidence of adverse effect is 8%in treatment group and 16%in control group,there is no significant difference between two groups, (P＞0.05).
Conclusions:
1.Zaoshu Yifang is better than Zhibaidihuang Pill in treating symptoms of deficiency of kidney-YIN and excessive stomach-fire such as dizziness,burning sensation of five centres,polyphagia,boulimia, prosopo-acne.
2.Zaoshu Yifang can significantly diminish enlarged breasts,womb and ovaries,and its therapeutic effect is better than that of Zhibaidihuang Pill.
3.Zaoshu Yifang not only can decrease the E_2 level in the body but also can decrease the FSH and LH level,which maybe is a proof that it can inhibit HPGi axle of ICPP sufferers.
4.Zaoshu Yifang has no impact to GH while decreasing sex hormone level in children with ICPP.And growth rate of bone age in ICPP sufferers is lower than that in Zhibaidihuang Pill group.It is a proof that it has little inhibition effect to growth hormone axle,further more,advanced bone age in ICPP sufferers is slowed down,which will increase growth potential of the children.
5.Zaoshu Yifang is a safe method in treating girls with ICPP.
研究目的:通过观察治疗前后患儿青春期性征、体重、身高、骨龄等的变化,进一步对早熟一方治疗ICPP临床疗效进行科学的论证;通过观察治疗前后患儿血清FSH、LH、E_2水平的变化,了解早熟一方对患儿激素水平的影响;通过观察治疗前后患儿血清中GH变化,了解早熟一方对患儿生长激素水平的影响;并试图探讨促生长激素轴及促性腺轴之间的相互关系,以及它们在ICPP发病机制中的作用,从而进一步探讨早熟一方的作用机制。
本研究从患儿血清中GH的变化以及与FSH、LH、E_2的变化间的相互关系,试图了解促生长激素轴和促性腺轴之间的相互关系,并从这些全新的角度探讨ICPP的发病机制及早熟一方治疗ICPP的作用机理,证实滋阴降火清胃法治疗本病的优势所在和特点及其药物安全性,为中医药治疗本病提供新的治疗思路和途径。
研究方法:研究对象共50例女童,均为2006年1月—2008年3月在广州市中医医院儿科门诊就诊并确诊为ICPP的女童,按就诊先后顺序随机分为治疗组和对照组各25例,治疗组予早熟一方口服,每日2次;对照组予知柏地黄丸,每次6丸,每日2次。两组用药时间均为6个月,治疗期间均无合并其他疗法。治疗前后对临床症状、体征、FSH、LH、E_2、GH、盆腔B超、骨龄、体重、身高、肝肾功能等进行比较。全部数据以均数±标准差((?)±s)表示,组间比较:方差齐的采用两组独立样本的t检验,方差不齐的采用秩和检验;治疗前后比较采用配对样本的t检验;计数资料采用x~2检验。分析均由SPSS11.3软件包完成。
结果:
1.两组疗效比较:
两组总有效率分别为:治疗组88%,对照组56%,两组比较有显著性差异(P＜0.05)。
2.两组临床症状缓解的起效时间:
两组头晕、五心烦热、多食善饥、面部痤疮的缓解起效时间比较有显著性差异(P＜0.05),而潮热、盗汗的缓解起效时间比较无显著性差异(P＞0.05)。
3.两组治疗前后乳房直径:
两组治疗前后乳房大小比较均有显著性差异(P＜0.05)。但两组治疗前乳房大小比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
4.子宫、卵巢体积:
治疗组治疗前后子宫体积比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。且两组治疗前子宫体积比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
5.血清FSH水平:
治疗组治疗前后血清FSH比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。且两组治疗前血清FSH比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
6.血清LH水平:
治疗组治疗前后血清LH比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。而两组治疗前后血清LH比较无显著性差异(P＞0.05)。
7.血清E_2水平:
两组治疗前后血清E_2比较均有显著性差异(P＜0.05)。但两组治疗前血清E_2比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
8.GH水平:
两组治疗前后血清生长激素比较均无显著性差异(P＞0.05)。两组治疗前后血清生长激素比较亦无显著性差异(P＞0.05)。
9.BA/CA(骨龄/实际年龄):
治疗组治疗前后BA/CA比较有显著性差异(P＜0.05),而对照组治疗前后比较差异无显著性(P＞0.05)。两组治疗前血清BA/CA比较无显著性差异(P＞0.05),而治疗后比较差异有显著性(P＜0.05)。
10.两组治疗前后身高、体重比较无显著性差异(P＞0.05)。
11.药物的不良反应:治疗组不良反应总发生率8%,对照组不良反应总发生率16%,两组比较无显著性差异(P＞0.05)。
结论:
1.早熟一方对头晕、五心烦热、多食善饥、面部痤疮等肾阴亏虚、胃火旺盛等症状的疗效优于知柏地黄丸。
2.早熟一方可缩小患儿肿大的乳房及增大的子宫和卵巢体积,且效果优于知柏地黄丸。
3.早熟一方不仅可降低ICPP患儿体内E_2水平,还可降低其血清FSH、LH水平,说明其可能具有抑制ICPP患儿HPGA轴的功能。
4.早熟一方在降低ICPP患儿体内性激素水平的同时GH水平没有降低。且患儿骨龄增长速度低于知柏地黄丸组。间接证明其对于生长激素轴没有明显的抑制,且患儿骨龄超前得以一定程度缓解,生长潜力增高。
5.早熟一方治疗组不良反应发生率低,应用本方治疗女童ICPP是安全可行的。
Background:
Precocious puberty is a kind of growth and developmental abnormality that is characterized as premature start of adolescence and secondary sexual character,among which idiopathic central precocious puberty(ICPP)is the most common one(92%of children with precocious puberty).Researches show it has impact on children' s physiology,mental health,lives and study;it can also effect the development of bone age and body height.In recent years, prevalence of precocious puberty increases steadily and it has become a common endocrine disease in children.80%-90%of endocrine disease in girls is ICPP, so ICPP in girls has become the focus in the study of precocious puberty.Until now its etiology is unclear,which is believed to be the result of activation of HPGA in advance.In western medicine,gonadotropin releasing hormone analogues(GnRHa)are the usual agent in treating ICPP of girls.GnRHa are expensive and its safety needs further appraisal because of its short application period in clinics,further more,it is report to inhibit secretion of GH and has negative impact to body height in recent years.It is thought from the point of TCM that normal growth and development and maturation of genital gland mainly depend on sufficient kidney-qi and menstruation beginning on time.If there are imbalance between kidney-yin and kidney-yang and menstruation is ahead of time,it will cause disease by bringing sexual maturity of children forward.It is regarded that the main etiology and pathogenesis of precocious puberty is:inefficiency of kidney-yin;pathogenic fire derived from stagnation of liver-QI;stagnation of phlegm caused by splenic asthenia;flowing down of pathogenic damp and etc.But in clinic inefficiency of kidney-yin and asthenic yin causing excessive pyrexia are the main symptoms of girls with ICPP.In clinic,we find that children with ICPP are always accompanied with symptoms of excessive gastric heat and hyperactivity of deficient fire such as polyphagia,easy to be hungry and acne in the face besides asthenic yin causing excessive pyrexia.During treatment of the disorder with traditional Chinese medicine(TCM),we found that TCM can not only decrease secondary sexual character of children patients,but also decrease serum level of sex hormone(FSH,LH,E_2)and has no impact to growth and development of the children during treating period.In the study, based on pathologic character of "yin frequently in deficiency,yang frequently in excess" and "liver frequently in excess,asthenic susceptibility of kidney" in children,we propose nourishing yin to lessen fire and clear stomach as therapeutical principle and prescribed Zaoshu Yifang to treat ICPP.We choose hormone(FSH,LH,E_2,GH)level in serum as the main index and ultrasound examination Of pelvic cavity,bone age,body weight,body height and clinical symptoms as parameters of curative effect.From the study, we hope to further investigate influence of TCM to functional activity of HPGA and somatotropic hormone-axle,hormone level in serum,growth and development.
Objective:
Appraisal clinical curative effect of Zaoshu Yifang to ICPP in scientific manner by observation of changes of sexual characteristics during adolescence, body weight,body height and bone age before and after the treatment; investigate impact of Zaoshu Yifang to hormone level of children patients by observation of changes of FSH,LH and E2 before and after the treatment;by observation of changes of GH level,study impact of Zaoshu Yifang to growth hormone of children patients,investigate interrelationship between somatotropic hormone-axle and gonadotropic hormone-axle and their role in pathogenesis of ICPP and further study the mechanism of action of Zaoshu Yifang.
In the study,we try to study interrelationship between somatotropic hormone-axle and gonadotropic hormone-axle from changes of GH level and its relationship with changes of FSH,LH and E2,investigate pathogenesis of ICPP and mechanism of action of Zaoshu Yifang to ICPP from these fresh new point of view,verify advantages of nourishing yin to lessen fire and clear kidney in treating the disorder and drug safety and provide new therapeutic method in treating the disorder by TCM.
Methods:
50 girls diagnosed to be ICPP in outpatient pediatric clinic in Guangzhong Hospital of Chinese Medicine(from January,2006 to April,2008)were randomly divided into treatment group and control group with 25 girls in each group. Treatment group were treated with Zaoshu Yifang,twice per day;Control group were treated with Zhibaidihuang Pill,6 pills per time,twice per day.Treating time is 6 months in both groups and without additional treatment.Clinical symptoms and signs,FSH,LH,E_2,GH,ultrasound examination of pelvic cavity, bone age,body weight,body height,liver function and renal function were compared before and after treatment.Results were showed as X±s.Group comparison:independent t test was used for homogeneity of variance and rank sum test was used for heterogeneity of variance.Comparison before and after treatment:paired t test was used for measurement data andχ~2 test was used for enumeration data.SPSS11.3 software was used for analysis.
Results:
1.Comparison of therapeutic effect:
There is significant difference of total effective rate between two groups (88%in treatment group and 56%in control group,P＜0.05).
2.Symptomatic relief time:
There is significant difference of symptomatic relief time between two groups in the symptom such as dizziness,burning sensation of five centres, polyphagia,boutimia,prosopo-acne(P＜0.05).But,there is no significant difference of symptomatic relief time between two groups in the symptom such as hectic fever、night sweat(P＞0.05).
3.Breasts diameter:
There is significant difference in breasts diameter before and after treatment both in two groups(P＜0.05).But,there is no significant difference between two groups before treatment(P＞0.05),there is significant difference between two groupsafter treatment(P＜0.05).
4.Volume of womb and ovaries:
There is significant difference in volume of womb and ovaries before and after treatment in treatment group(P＜0.05).But,there is no significant difference in volume of womb and ovaries before and after treatment in control group(P＞0.05).There is no significant difference between two groups before treatment(P＞0.05).And,there is significant difference between two groups after treatment(P＜0.05)
5.FSH level:
There is significant difference in FSH level before and after treatment in treatment group(P＜0.05)But,there is no significant difference in FSH level before and after treatment in control group(P＞0.05)There is no significant difference between two groups before treatment(P＞0.05)But, there is significant difference between two groups after treatment(P＜0.05).
6.LH level:
There is significant difference in LH level before and after treatment in treatment group(P＜0.05).But,there is no significant difference in LH level before and after treatment in control group(P＞0.05).There is no significant difference between two groups before and after treatment(P＞0.05).
7.E_2 level:
There is significant difference in E_2 level before and after treatment both in two groups(P＜0.05).There is no significant difference between two groups before treatment(P＞0.05)But,there is significant difference between two groups after treatment(P＜0.05).
8.GH level:
There is significant difference in E_2 level before and after treatment both in two groups(P＞0.05).And there is no significant difference between two groups before and after treatment(P＞0.05).
9.BA/CA(bone age/actual age):
There is significant difference in BA/CA before and after treatment in treatment group(P＜0.05).But,there is no significant difference in BA/CA before and after treatment in control group(P＞0.05).There is no significant difference between two groups before treatment(P＞0.05),But,there is significant difference between two groups after treatment(P＜0.05).
10.There is no significant difference of body height and body weight between two groups before and after treatment(P＞0.05).
11.idverse effect of the drug:
Total incidence of adverse effect is 8%in treatment group and 16%in control group,there is no significant difference between two groups, (P＞0.05).
Conclusions:
1.Zaoshu Yifang is better than Zhibaidihuang Pill in treating symptoms of deficiency of kidney-YIN and excessive stomach-fire such as dizziness,burning sensation of five centres,polyphagia,boulimia, prosopo-acne.
2.Zaoshu Yifang can significantly diminish enlarged breasts,womb and ovaries,and its therapeutic effect is better than that of Zhibaidihuang Pill.
3.Zaoshu Yifang not only can decrease the E_2 level in the body but also can decrease the FSH and LH level,which maybe is a proof that it can inhibit HPGi axle of ICPP sufferers.
4.Zaoshu Yifang has no impact to GH while decreasing sex hormone level in children with ICPP.And growth rate of bone age in ICPP sufferers is lower than that in Zhibaidihuang Pill group.It is a proof that it has little inhibition effect to growth hormone axle,further more,advanced bone age in ICPP sufferers is slowed down,which will increase growth potential of the children.
5.Zaoshu Yifang is a safe method in treating girls with ICPP.
引文
[1]颜纯,王慕逖.《小儿内分泌学》,北京:人民卫生出版社,2007,1:233
[2]Rogol A,Blizzard RM,Kappy M S,eds.the diagnosis and treatment of endocrine disorders in childhood and adolescence.Springfield,1994;11:857-917
[3]杜敏联,马华梅,陈香琼.促性腺素释放激素类似物对特发性中枢性性早熟女孩生长的影响.中华内分泌代谢杂志,2000;16(5):277
[4]吴家敏.儿童性早熟中西医治疗进展.上海中医药杂志,2003;37(3):63
[5]Garbaldi L.Disorder of pubertal development In:Behrman RE,Kliegman RM,Jenson HB,Nelson textbook of pediatrics,Philadelphia:WB Saunders Company,2004,1:1863-1870.
[6]Peter A.Central precocious puberty.Pediatr Endocrinol,1999:28(4):901-907
[7]Lee PA.Adwances in the manament of precocious puberty.Clin Pediatr,1994:33(1):54-61
[8]Neely EK,Wilson DM,hee PA,etal.Spontaneous serum gonadotropin concentration assays.J Pediatr,1995;127(1):47-52
[9]孙跃玉,李海浪.特发性中枢性性早熟的发病机制及其诊断.国外医学儿科学分册,2002:29(2):98
[10]Bridge NA,Healy MJ.Ovaries in sexual precocity.Clin Endocrinol,1995:42(2):135-140
[11]蔡德培.性早熟治疗及药物作用机制的研究进展.实用儿科临床杂志,2005;20(6):502-503
[12]Meir LM,Avraham G,Hadassah Getal.Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty,a pilot study,2002:87(2):687
[13]Walvoord EC,Pescovitz OH.Combined use of growth hormone and gonadotropin -releasing hormone analogues in precocious puberty.Theoretic and pratical consideration Pediatrics,1999:104:1010-1414
[14]Pucarelli I,Segni M,Ortore M,etal.Combined therapy with GnRH analog plus grow hormone in central precocious puberty.Pediatr Endocrinol Metab,2000:1(1):811-820
[15]Barash IA,Chung CC,Weigle DS,etal.Leptin is a metabolic signal to the reproductive system.Endocrinology,1996:137:3144-3147
[16]蔡德培,时毓民.性早熟女童阴虚火旺证本质的探讨.中西医结合杂志,1991;11(7):397
[17]陈永辉.儿童性早熟的辨治经验.中医杂志,1998;39(1):19
[18]杨美琳,刘妍,申巧靖.知柏地黄丸治疗儿童性早熟25例结果分析.河南中医, 1999:19(0):59
[19]夏龙江,肖挹.三草汤治疗女童性早熟23例.实用医学临床杂志,2004;1(1):92
[20]李伟元,邓丽莎,莫珊.滋阴降火法治疗女童真性性早熟28例.辽宁中医杂志,2004:31(3):2292-2301
[21]赵均,虞坚尔.小儿性早熟中医药治疗进展.山西中医学院学报,2000;23(4):561
[22]秦萍.柴胡橘叶汤治疗女童特发性中枢性性早熟30例.上海中医药杂志,2004;38(4):352-361
[23]陈智清.中药对特发性性早熟女孩骨龄的影响.中国中西医结合杂志,2000;20(1):41
[24]马乃珏.中药治疗性早熟12例.陕西中医,1998;19(2):52
[25]高华,刘云鹏.治疗女童特发性性早熟经验.湖北中医杂志,2004;26(12):13-14
[26]蔡德培.滋阴泻火中药为主对改善性早熟儿童骨骼发育作用及机理的探讨.中医杂志,1997;38(10):615-617
[27]杨立础,张字,黄建婷.中西医结合治疗女童特发性中枢性性早熟28例.中国中西医结合杂志,2002;(10):749
[28]傅美娣,蔡德培,时毓民.中西医结合治疗女童性早熟30例.辽宁中医杂志,1997;(5):225-226
[29]李海浪,郑意楠,蔡德培.滋阴泻火中药治疗女孩特发性真性性早熟.铁道医学,1999:(2):101-102
[30]顾再研.滋阴泻火中药治疗性早熟女童38例临床分析.实用中西医结合杂志,1998:(4):353
[31]徐银芳.浅谈儿童性早熟的辨证论治.山西中医,2002;18(12):5762-5771
[32]刘百祥.逍遥散加味治疗女童性早熟34例.湖南中医杂志,2004;20(4):61
[33]何平,朱瑛.刘以敏主任治疗小儿性早熟经验.云南中医中药杂志,2004;25(6):12-21
[34]赵鋆,虞坚尔.抗早2号方治疗女童真性性早熟的临床研究.中国中西医结合杂志,2003;23(3):1822-1841
[35]蔡德培,陈伯英,庄振杰.滋阴泻火中药对下丘脑GnRH的合成、分泌及其调节机制的影响.中国中西医结合杂志,200l;21(8):595-598
[36]田占庄,赵宏,陈伯英.滋阴泻火中药对性早熟模型大鼠促性腺激素释放激素及其受体mRNA表达的影响.中国中西医结合杂志,2003;23(9):695-698
[37]陆炜,蔡德培.补肾中药对雌性青春期大鼠垂体GnRH受体mRNA及其受体蛋白表达的影响.中国中西医结合杂志,2003;23(2):120-122
[38]沈自尹,蔡德培.从分子水平研究补肾法对性早熟与衰老的调控规律.中国中西医 结合杂志,2005;25(6):549-551
[39]俞建,吴家敏,杨毅等.滋阴泻火中药对大鼠中枢生长相关基因的影响.中国医药学报,2004;19:15-17
[40]李嫔,蔡德培.补肾中药对青春期大鼠下丘脑生长抑素基因表达与蛋白表达的影响.上海中医药杂志,2003;37:50-52
[41]蔡德培,季志英,陈伯英等.Pathogenetic regularity of female precocious puberty and the mechaniss of therapy with traditional Chinese medicine.中国中西医结合杂志(英文版),200l;7(2):132-134
[42]陈祺.小儿早熟Ⅰ号治疗女童性早熟69例.河南中医,2003;23(7):53-54
[43]徐雯,邱志雯.加减知柏地黄汤治疗特发性性早熟女童42例.中医杂志,2007;48(4):335
[44]陈崇毅,方益屏.滋阴降火中药治疗女童性早熟临床观察.浙江中西医结合杂志,2000;10(2):76-77
[45]王泽润,顾红娟.滋阴降火中药治疗女童特发性中枢性性早熟30例.天津医药,2004:32(7):452-453
[46]李凤云.中西医结合治疗女性特发性性早熟30例.河南中医学院学报,2006;3(2):62-63
[47]张巨明,华苓,钱进等.中药治疗女童真性性早熟的临床观察.中国中药杂志,2005:30(17):1367-1369
[48]姜春华.《肾脏研究》,上海:上海科学技术出版社,1991,2:268
[49]蔡德培,陈伯英,张炜等.中药调整性早熟儿童青春发育进程的机制研究.中西医结合学报,2006;4(2):166-174
[2]Rogol A,Blizzard RM,Kappy M S,eds.the diagnosis and treatment of endocrine disorders in childhood and adolescence.Springfield,1994;11:857-917
[3]杜敏联,马华梅,陈香琼.促性腺素释放激素类似物对特发性中枢性性早熟女孩生长的影响.中华内分泌代谢杂志,2000;16(5):277
[4]吴家敏.儿童性早熟中西医治疗进展.上海中医药杂志,2003;37(3):63
[5]Garbaldi L.Disorder of pubertal development In:Behrman RE,Kliegman RM,Jenson HB,Nelson textbook of pediatrics,Philadelphia:WB Saunders Company,2004,1:1863-1870.
[6]Peter A.Central precocious puberty.Pediatr Endocrinol,1999:28(4):901-907
[7]Lee PA.Adwances in the manament of precocious puberty.Clin Pediatr,1994:33(1):54-61
[8]Neely EK,Wilson DM,hee PA,etal.Spontaneous serum gonadotropin concentration assays.J Pediatr,1995;127(1):47-52
[9]孙跃玉,李海浪.特发性中枢性性早熟的发病机制及其诊断.国外医学儿科学分册,2002:29(2):98
[10]Bridge NA,Healy MJ.Ovaries in sexual precocity.Clin Endocrinol,1995:42(2):135-140
[11]蔡德培.性早熟治疗及药物作用机制的研究进展.实用儿科临床杂志,2005;20(6):502-503
[12]Meir LM,Avraham G,Hadassah Getal.Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty,a pilot study,2002:87(2):687
[13]Walvoord EC,Pescovitz OH.Combined use of growth hormone and gonadotropin -releasing hormone analogues in precocious puberty.Theoretic and pratical consideration Pediatrics,1999:104:1010-1414
[14]Pucarelli I,Segni M,Ortore M,etal.Combined therapy with GnRH analog plus grow hormone in central precocious puberty.Pediatr Endocrinol Metab,2000:1(1):811-820
[15]Barash IA,Chung CC,Weigle DS,etal.Leptin is a metabolic signal to the reproductive system.Endocrinology,1996:137:3144-3147
[16]蔡德培,时毓民.性早熟女童阴虚火旺证本质的探讨.中西医结合杂志,1991;11(7):397
[17]陈永辉.儿童性早熟的辨治经验.中医杂志,1998;39(1):19
[18]杨美琳,刘妍,申巧靖.知柏地黄丸治疗儿童性早熟25例结果分析.河南中医, 1999:19(0):59
[19]夏龙江,肖挹.三草汤治疗女童性早熟23例.实用医学临床杂志,2004;1(1):92
[20]李伟元,邓丽莎,莫珊.滋阴降火法治疗女童真性性早熟28例.辽宁中医杂志,2004:31(3):2292-2301
[21]赵均,虞坚尔.小儿性早熟中医药治疗进展.山西中医学院学报,2000;23(4):561
[22]秦萍.柴胡橘叶汤治疗女童特发性中枢性性早熟30例.上海中医药杂志,2004;38(4):352-361
[23]陈智清.中药对特发性性早熟女孩骨龄的影响.中国中西医结合杂志,2000;20(1):41
[24]马乃珏.中药治疗性早熟12例.陕西中医,1998;19(2):52
[25]高华,刘云鹏.治疗女童特发性性早熟经验.湖北中医杂志,2004;26(12):13-14
[26]蔡德培.滋阴泻火中药为主对改善性早熟儿童骨骼发育作用及机理的探讨.中医杂志,1997;38(10):615-617
[27]杨立础,张字,黄建婷.中西医结合治疗女童特发性中枢性性早熟28例.中国中西医结合杂志,2002;(10):749
[28]傅美娣,蔡德培,时毓民.中西医结合治疗女童性早熟30例.辽宁中医杂志,1997;(5):225-226
[29]李海浪,郑意楠,蔡德培.滋阴泻火中药治疗女孩特发性真性性早熟.铁道医学,1999:(2):101-102
[30]顾再研.滋阴泻火中药治疗性早熟女童38例临床分析.实用中西医结合杂志,1998:(4):353
[31]徐银芳.浅谈儿童性早熟的辨证论治.山西中医,2002;18(12):5762-5771
[32]刘百祥.逍遥散加味治疗女童性早熟34例.湖南中医杂志,2004;20(4):61
[33]何平,朱瑛.刘以敏主任治疗小儿性早熟经验.云南中医中药杂志,2004;25(6):12-21
[34]赵鋆,虞坚尔.抗早2号方治疗女童真性性早熟的临床研究.中国中西医结合杂志,2003;23(3):1822-1841
[35]蔡德培,陈伯英,庄振杰.滋阴泻火中药对下丘脑GnRH的合成、分泌及其调节机制的影响.中国中西医结合杂志,200l;21(8):595-598
[36]田占庄,赵宏,陈伯英.滋阴泻火中药对性早熟模型大鼠促性腺激素释放激素及其受体mRNA表达的影响.中国中西医结合杂志,2003;23(9):695-698
[37]陆炜,蔡德培.补肾中药对雌性青春期大鼠垂体GnRH受体mRNA及其受体蛋白表达的影响.中国中西医结合杂志,2003;23(2):120-122
[38]沈自尹,蔡德培.从分子水平研究补肾法对性早熟与衰老的调控规律.中国中西医 结合杂志,2005;25(6):549-551
[39]俞建,吴家敏,杨毅等.滋阴泻火中药对大鼠中枢生长相关基因的影响.中国医药学报,2004;19:15-17
[40]李嫔,蔡德培.补肾中药对青春期大鼠下丘脑生长抑素基因表达与蛋白表达的影响.上海中医药杂志,2003;37:50-52
[41]蔡德培,季志英,陈伯英等.Pathogenetic regularity of female precocious puberty and the mechaniss of therapy with traditional Chinese medicine.中国中西医结合杂志(英文版),200l;7(2):132-134
[42]陈祺.小儿早熟Ⅰ号治疗女童性早熟69例.河南中医,2003;23(7):53-54
[43]徐雯,邱志雯.加减知柏地黄汤治疗特发性性早熟女童42例.中医杂志,2007;48(4):335
[44]陈崇毅,方益屏.滋阴降火中药治疗女童性早熟临床观察.浙江中西医结合杂志,2000;10(2):76-77
[45]王泽润,顾红娟.滋阴降火中药治疗女童特发性中枢性性早熟30例.天津医药,2004:32(7):452-453
[46]李凤云.中西医结合治疗女性特发性性早熟30例.河南中医学院学报,2006;3(2):62-63
[47]张巨明,华苓,钱进等.中药治疗女童真性性早熟的临床观察.中国中药杂志,2005:30(17):1367-1369
[48]姜春华.《肾脏研究》,上海:上海科学技术出版社,1991,2:268
[49]蔡德培,陈伯英,张炜等.中药调整性早熟儿童青春发育进程的机制研究.中西医结合学报,2006;4(2):166-174